Evaluation of the clinical course and consequences of disease in the children suspicious to Covid-19 who have/have not received Antibiotics

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220116053739N1

Enrollment

Registered

2022-04-15

Start date

2021-09-28

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19. Covid 19

Interventions

Intervention 1: Patients in the intervention group were treated with a group of antibiotics with gram-negative and gram-positive coverage (third generation cephalosporin). Third-generation cephalospor

Eligibility

Sex/Gender

All

Age

2 Years to 14 Years

Inclusion criteria

Inclusion criteria: The patient with IgM positive The patient with confirmed molecular test

Exclusion criteria

Exclusion criteria: Having the background of Underlying disease Any clinical or laboratory evidence of the patient need for Antibiotics Lack of consent of the patient and his/her family for the participation in the study

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: Time of discharge from the hospital. Method of measurement: Number of days hospitalized.;Complete blood count (CBC). Timepoint: Day of hospitalization, seven days after hospitalization. Method of measurement: Use of cell counting machine.;Fever. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Thermometer.;Cough. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Asking the patient.	—

Measure

Time frame

Duration of hospitalization. Timepoint: Time of discharge from the hospital. Method of measurement: Number of days hospitalized.;Complete blood count (CBC). Timepoint: Day of hospitalization, seven days after hospitalization. Method of measurement: Use of cell counting machine.;Fever. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Thermometer.;Cough. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Asking the patient.

—

Secondary

Measure	Time frame
Test result of Troponin. Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Troponin test kit.;D-dimer. Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Latex agglutination test.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: The Westergren method.;C-reactive protein test (CRP). Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Latex agglutination test.;Anorexia. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Asking the patient.	—

Measure

Time frame

Test result of Troponin. Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Troponin test kit.;D-dimer. Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Latex agglutination test.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: The Westergren method.;C-reactive protein test (CRP). Timepoint: Day of hospitalization and seven days after hospitalization. Method of measurement: Latex agglutination test.;Anorexia. Timepoint: Day of hospitalization, seven days after hospitalization and One month after hospitalization. Method of measurement: Asking the patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mohsenifar

Shahre-kord University of Medical Sciences

amin_mohsenifar@outlook.com0983833335833

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026